Back
Arcutis Biotherapeutics Stock Price Chart
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion Superproject
Buy
55
ARQT
Arcutis Biotherapeutics
Last Price:
9.61
Seasonality Move:
-17.15%
7 Day Trial
ALL ACCESS PASS
$
7
Buy a stock when it crosses this line on the chart
Here's the line to follow.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARQT is experiencing slight selling pressure.
Arcutis Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.37 | Buy |
| 20-day SMA: | 8.6 | Buy |
| 50-day SMA: | 8.6 | Buy |
| 200-day SMA: | 6.41 | Buy |
| 8-day EMA: | 9.27 | Buy |
| 20-day EMA: | 8.92 | Buy |
| 50-day EMA: | 8.8 | Buy |
| 200-day EMA: | 8.25 | Buy |
Arcutis Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 58.71 | Buy |
| Chaikin Money Flow: | -26291 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.85 - 9.25) | Buy |
| Bollinger Bands (100): | (8.06 - 10.52) | Buy |
Arcutis Biotherapeutics Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Arcutis Biotherapeutics Stock
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 9.60 while ARQT 8-day simple moving average is 9.37, which is a Buy signal.
- The stock price of ARQT is 9.60 while Arcutis Biotherapeutics 20-day SMA is 8.60, which makes it a Buy.
- Arcutis Biotherapeutics 50-day simple moving average is 8.60 while ARQT share price is 9.60, making it a Buy technically.
- ARQT stock price is 9.60 and Arcutis Biotherapeutics 200-day simple moving average is 6.41, creating a Buy signal.
ARQT Technical Analysis vs Fundamental Analysis
Buy
55
Arcutis Biotherapeutics (ARQT)
is a Buy
Is Arcutis Biotherapeutics a Buy or a Sell?
-
Arcutis Biotherapeutics stock is rated a Buy
The current Arcutis Biotherapeutics [ARQT] share price is $9.60. The Score for ARQT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Arcutis Biotherapeutics Stock Info
Market Cap:
1.11B
Price in USD:
9.60
Share Volume:
1.55M
Arcutis Biotherapeutics 52-Week Range
52-Week High:
13.17
52-Week Low:
1.76
Buy
55
Arcutis Biotherapeutics (ARQT)
is a Buy
Arcutis Biotherapeutics Share Price Forecast
-
What is the Arcutis Biotherapeutics stock price today?
The Arcutis Biotherapeutics stock price is 9.60 USD today. -
Will ARQT stock go up or go down?
Arcutis Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Arcutis Biotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arcutis Biotherapeutics is not overvalued.
Is Arcutis Biotherapeutics Stock a Buy?
- Arcutis Biotherapeutics share price is 9.60 while ARQT 8-day exponential moving average is 9.27, which is a Buy signal.
- The stock price of ARQT is 9.60 while Arcutis Biotherapeutics 20-day EMA is 8.92, which makes it a Buy.
- Arcutis Biotherapeutics 50-day exponential moving average is 8.80 while ARQT share price is 9.60, making it a Buy technically.
- ARQT stock price is 9.60 and Arcutis Biotherapeutics 200-day simple moving average is 8.25, creating a Buy signal.
Fundamental Analysis of Arcutis Biotherapeutics
Is Arcutis Biotherapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.25 per share, and an increase next year of $0.48 per share.
Technical Analysis of Arcutis Biotherapeutics
Should I short Arcutis Biotherapeutics stock?
- ARQT Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting Arcutis Biotherapeutics is a Buy
- Arcutis Biotherapeutics Relative Strength Index (RSI) is 58.71, which suggest Arcutis Biotherapeutics is overbought
- The Bollinger Bands (25) for Arcutis Biotherapeutics is (7.85 - 9.25), which suggest Arcutis Biotherapeutics is a Buy
- The Bollinger Bands (100) for Arcutis Biotherapeutics is (8.06 - 10.52), which suggest Arcutis Biotherapeutics is a Buy
* Arcutis Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.